Hale v. MacLeod

CourtCourt of Appeals of North Carolina
DecidedJune 18, 2024
Docket23-285
StatusPublished

This text of Hale v. MacLeod (Hale v. MacLeod) is published on Counsel Stack Legal Research, covering Court of Appeals of North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hale v. MacLeod, (N.C. Ct. App. 2024).

Opinion

IN THE COURT OF APPEALS OF NORTH CAROLINA

No. COA23-285

Filed 18 June 2024

Buncombe County, No. 21 CVS 3299

MIKE HALE, Plaintiff,

v.

WILLIAM ERIC MACLEOD, MD, JONATHAN PAGE, and GREEN FARMS COMPANY, LLC, Defendants.

Appeal by plaintiff from an order entered 29 August 2022 by Judge Daniel A.

Kuehnert in Buncombe County Superior Court. Heard in the Court of Appeals 20

September 2023 in session at Wake Forest University School of Law in the City of

Winston-Salem pursuant to N.C. Gen. Stat. § 7A-19(a).

Law Offices of Matthew K. Rogers, PLLC, by Matthew K. Rogers, and Allen Stahl & Kilbourne, PLLC, by James. W. Kilbourne, Jr. for plaintiff-appellant.

Fitzgerald Hanna & Sullivan, PLLC, by Douglas W. Hanna, for Jonathan Page, defendant-appellee.

WOOD, Judge.

Mike Hale (“Hale”) appeals the trial court’s 29 August 2022 order dismissing

with prejudice his complaint against Green Farms Company, LLC (“GF Co.”), its

Manager William MacLeod (“MacLeod”), and its CEO, Jonathan Page (“Page”),

alleging numerous causes of action involving fraud, securities fraud, breach of

fiduciary duties, breach of contract, and unfair and deceptive trade practices. GF Co.

operated in the hemp and CBD industry. We affirm in part and reverse in part. HALE V. MACLEOD

Opinion of the Court

I. Factual and Procedural History

Hale and his wife were friends with MacLeod’s sister, who at some point

introduced them to MacLeod. Hale learned MacLeod was an orthopedic surgeon who

was no longer practicing medicine but was now involved in successful business

ventures. On or about 8 March 2020, Hale met with MacLeod to discuss MacLeod’s

business ventures, including hemp and cannabidiol (“CBD”). During their meeting,

Hale told MacLeod that he was interested in investing in local business opportunities.

That same day, Hale emailed MacLeod to say that he was specifically interested in

participating in the initial round of funding for the hemp and CBD business.

Thereafter, MacLeod introduced Hale to Page, the CEO of GF Co. MacLeod and Page

told Hale that MacLeod was the majority and controlling shareholder of GF Co., and

that they both were personally liable for the success of GF Co.

On 12 March 2020, all three men participated in a Zoom video conference call

during which Page and MacLeod made representations regarding the state of GF Co.

and the hemp and CBD industries. After the call, Page sent two documents to Hale

via email: (1) a competitive analysis to help Hale better understand the CBD market,

key players in it, and GF Co.’s market share, and (2) a four-year Cash Flow Return

on Investment projection analysis. In further emails, Page and MacLeod discussed

in detail GF Co.’s current business, customers, financial information, and confidential

information. Page represented in writing that the Return-on-Investment analysis

showed: “$5 [million] invested for 10% of the company generates 7.2 x cash on cash

-2- HALE V. MACLEOD

return in 4 years. This is merely the gain on the interim distributions made from

cash (not on a liquidation event). Additional gain would be realized on years 5 and

forward on liquidation.” Page also represented in writing that GF Co. had engaged

Emmet Moore (“Moore”), a Certified Public Accountant, as “CFO and VP of Finance.”

Page wrote that Moore had previous experience of executing two IPOs (Initial Public

Offerings), raising over $2 billion in debt and equity financing, and managing

extensive mergers and acquisitions activity. Later in March, Moore made

representations to Page regarding GF Co.’s financial condition and continuing growth

prospects, as well as his own confidence in and commitment to GF Co.’s management.

Page subsequently introduced Hale to Mark Van Kirk (“Van Kirk”). Page

informed Hale that Van Kirk was responsible for putting together a financial

instrument for GF Co. MacLeod, Van Kirk, and Page each stated to Hale that to

ensure he would be repaid funds, they wanted him to loan capital to GF Co. as a

secured creditor rather than taking an equity interest in GF Co.

MacLeod, Van Kirk, and Page provided Hale with a “capitalization table”

which represented GF Co. had a “Pre-Money Valuation” of $160,000,000.00 and had

already raised $20,770,550.00 in “Total Capital.” MacLeod and Page told Hale that

GF Co.’s assets were worth more than enough to ensure that, in the worst-case

scenario, Hale’s loan would be repaid in full in the event of liquidation of the business.

Subsequently, Van Kirk told Hale that he was not as confident in GF Co. as were

MacLeod and Page, and for that reason he insisted the deal be offered to Hale as a

-3- HALE V. MACLEOD

loan with personal guarantees from MacLeod and Page. Van Kirk explained that he

was involved in structuring and documenting a “convertible note” secured by GF Co.’s

assets and personally guaranteed by both MacLeod and Page.

On or about 2 July 2020, “at the direction, with the approval of and on behalf

of MacLeod,” Page provided Hale with a package of documents titled “Convertible

Note Investor Package” (the “Note Package”), dated June 2020. Hale signed the

Convertible Promissory Note on 2 July 2020 by which he agreed to loan $250,000.00

to GF Co.

The Note Package contains “Letters from Management” from both MacLeod

as Chairman and Page as CEO of GF Co. Page’s signed Personal Letter states, among

other things:

At Green Farms Co, we’ve made substantial progress towards scaling up this company to a billion-dollar valuation (with over $100 million in our deal pipeline today)[.] ...

That’s why I have chosen to personally guarantee this Note Series, pledging my personal balance sheet, because I see the CBD green rush right around the corner and I know with this next round of financing, Green Farms will be in the right position at the right time to seize it.

(Emphasis added).

The Note Package also contained a “Pro-Forma and Deck,” which was a

slideshow of information about GF Co.’s business prospects. The slideshow stated GF

Co. could “conservatively generate $18.6 MM in monthly revenues.” The “Pro-Forma

-4- HALE V. MACLEOD

and Deck” also contained a section titled “Capital Stock & Liquidation Analysis.”

This section represented that GF Co. had $20,770,550.00 “Total Capital” and

$399,595.00 “Senior Debt,” or just 1.9 percent of Total Capital. A slide titled “Pro

Forma Liquidation Scenario Analysis” stated GF Co.’s liquidation value as

$11,408,054.00, which included the projected value of assets purchased with capital

raised from the convertible note round. A slide titled “Green Farms Pipeline Detail”

listed prospective business with other companies at various stages of the negotiation

process—either “Contract”, “LOI” (Letter of Intent), or “Pipeline,” with most

prospective business opportunities being “Pipeline” opportunities. The projected

income statement predicted $22,945,191.00 in revenue by the end of 2020, and the

projected cash flow statement predicted positive cash flow beginning by the end of

2021.

A separate section of the “Pro-Forma and Deck” titled “Convertible Note

Round” detailed the “Convertible Note Terms.” “Key Terms” of the note included

“Full collateralization of principal by equipment from lab build-out and existing

equipment” and “Personal guarantees from [MacLeod] and [Page] and a corporate

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Farndale Co., LLC v. Gibellini
628 S.E.2d 15 (Court of Appeals of North Carolina, 2006)
Poor v. Hill
530 S.E.2d 838 (Court of Appeals of North Carolina, 2000)
Bob Timberlake Collection, Inc. v. Edwards
626 S.E.2d 315 (Court of Appeals of North Carolina, 2006)
Whitley v. Carolina Clinic, Inc.
455 S.E.2d 896 (Court of Appeals of North Carolina, 1995)
Hudson-Cole Development Corp. v. Beemer
511 S.E.2d 309 (Court of Appeals of North Carolina, 1999)
Howell v. Smith
134 S.E.2d 381 (Supreme Court of North Carolina, 1964)
Leary v. N.C. Forest Products, Inc.
580 S.E.2d 1 (Court of Appeals of North Carolina, 2003)
Ladd v. Estate of Kellenberger
334 S.E.2d 751 (Supreme Court of North Carolina, 1985)
Nutek Custom Hosiery, Inc. v. Roebuck
587 S.E.2d 502 (Court of Appeals of North Carolina, 2003)
Oberlin Capital, L.P. v. Slavin
554 S.E.2d 840 (Court of Appeals of North Carolina, 2001)
White v. Consolidated Planning, Inc.
603 S.E.2d 147 (Court of Appeals of North Carolina, 2004)
Schlieper v. Johnson
672 S.E.2d 548 (Court of Appeals of North Carolina, 2009)
Terry v. Terry
273 S.E.2d 674 (Supreme Court of North Carolina, 1981)
Williams v. . Williams
18 S.E.2d 364 (Supreme Court of North Carolina, 1942)
Christenbury Eye Ctr., P.A. v. Medflow, Inc.
802 S.E.2d 888 (Supreme Court of North Carolina, 2017)
Builders Mutual Ins. v. Glascarr Properties, Inc.
688 S.E.2d 508 (Court of Appeals of North Carolina, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Hale v. MacLeod, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hale-v-macleod-ncctapp-2024.